China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 10.2% in First Quarter of 2023

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 380.6 million yuan in the first quarter of 2023, up 10.2% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, up 8.8% year-on-year.

At the end of the reporting period, it had 14.8 billion yuan in total assets and 3.6 billion yuan in total liabilities, with a liability-to-asset ratio of 24.7%.